Numerous malignancies have been linked with DAPK-1 hypermethylation and loss of its expression, and these include bladder [78], kidney [79], gastric [80], head and neck [81], thyroid [82], lung [31], ovarian [83] and cervical cancers [71,72,76]. Here, DAPK1 is linked to cervical carcinoma.